End-of-day quote
Korea S.E.
03:30:00 16/07/2024 am IST
|
5-day change
|
1st Jan Change
|
6,600
KRW
|
-3.51%
|
|
-5.17%
|
-19.02%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
55,445
|
66,177
|
70,566
|
47,310
|
71,233
|
Enterprise Value (EV)
1 |
45,853
|
55,797
|
61,722
|
39,906
|
56,005
|
P/E ratio
|
-32.2
x
|
20.9
x
|
18.3
x
|
14.3
x
|
15.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.99
x
|
3.34
x
|
2.59
x
|
1.94
x
|
3.3
x
|
EV / Revenue
|
2.48
x
|
2.82
x
|
2.27
x
|
1.64
x
|
2.59
x
|
EV / EBITDA
|
12.6
x
|
13.7
x
|
9.4
x
|
8.17
x
|
10.7
x
|
EV / FCF
|
-25.6
x
|
105
x
|
110
x
|
-51.8
x
|
11.1
x
|
FCF Yield
|
-3.9%
|
0.96%
|
0.91%
|
-1.93%
|
9%
|
Price to Book
|
2.16
x
|
2.34
x
|
2.21
x
|
1.33
x
|
1.69
x
|
Nbr of stocks (in thousands)
|
8,170
|
8,170
|
8,218
|
8,271
|
8,740
|
Reference price
2 |
6,786
|
8,100
|
8,587
|
5,720
|
8,150
|
Announcement Date
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
16,434
|
18,526
|
19,788
|
27,201
|
24,346
|
21,589
|
EBITDA
1 |
3,548
|
3,635
|
4,061
|
6,565
|
4,882
|
5,216
|
EBIT
1 |
2,873
|
3,016
|
3,412
|
5,890
|
4,105
|
4,310
|
Operating Margin
|
17.48%
|
16.28%
|
17.24%
|
21.65%
|
16.86%
|
19.96%
|
Earnings before Tax (EBT)
1 |
2,561
|
-902.7
|
3,523
|
4,719
|
3,917
|
5,591
|
Net income
1 |
2,130
|
-1,405
|
3,123
|
4,004
|
3,252
|
4,583
|
Net margin
|
12.96%
|
-7.58%
|
15.78%
|
14.72%
|
13.36%
|
21.23%
|
EPS
2 |
387.0
|
-210.8
|
387.0
|
470.0
|
399.1
|
541.2
|
Free Cash Flow
1 |
1,314
|
-1,789
|
533.2
|
559.3
|
-770.9
|
5,041
|
FCF margin
|
8%
|
-9.66%
|
2.69%
|
2.06%
|
-3.17%
|
23.35%
|
FCF Conversion (EBITDA)
|
37.03%
|
-
|
13.13%
|
8.52%
|
-
|
96.63%
|
FCF Conversion (Net income)
|
61.69%
|
-
|
17.07%
|
13.97%
|
-
|
109.97%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,522
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
9,592
|
10,380
|
8,844
|
7,404
|
15,228
|
Leverage (Debt/EBITDA)
|
0.4291
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
1,314
|
-1,789
|
533
|
559
|
-771
|
5,041
|
ROE (net income / shareholders' equity)
|
21.1%
|
-7.63%
|
11.6%
|
13.4%
|
9.77%
|
11.9%
|
ROA (Net income/ Total Assets)
|
9.81%
|
7.86%
|
7.2%
|
10.1%
|
6.03%
|
6.05%
|
Assets
1 |
21,712
|
-17,864
|
43,362
|
39,731
|
53,921
|
75,741
|
Book Value Per Share
2 |
1,994
|
3,144
|
3,468
|
3,884
|
4,288
|
4,834
|
Cash Flow per Share
2 |
478.0
|
249.0
|
446.0
|
340.0
|
217.0
|
381.0
|
Capex
1 |
783
|
2,545
|
872
|
2,359
|
2,287
|
2,215
|
Capex / Sales
|
4.76%
|
13.74%
|
4.41%
|
8.67%
|
9.39%
|
10.26%
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
|
1st Jan change
|
Capi.
|
---|
| -19.02% | 41.64M | | +23.61% | 70.02B | | -3.98% | 47.08B | | +23.25% | 44.25B | | +35.36% | 29.07B | | +6.31% | 18.91B | | +13.16% | 17.15B | | -5.06% | 16.11B | | -28.83% | 14.28B | | -29.23% | 12.17B |
Other Specialty Chemicals
|